CVS Health (CVS) Tops Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $93.47 -1.07%
EPS Growth %: +3.1%
Financial Fact:
Loss from discontinued operations, net of tax: -1M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
EPS Growth %: +3.1%
Financial Fact:
Loss from discontinued operations, net of tax: -1M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q3 EPS of $1.73, $0.02 better than the analyst estimate of $1.71. Revenue for the quarter came in at $47.3 billion versus the consensus estimate of $47.2 billion.
GUIDANCE:
CVS Health sees FY2018 EPS of $6.98-$7.08, versus the consensus of $7.05.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- AMTD Digital reports $1.2B in total assets, $42.4M profit
- Infosys Limited (INFY) Reports In-Line Q3 EPS
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
